Lepirudin for Heparin-Induced Thrombocytopenia
Lepirudin (Refludan - Hoechst Marion Roussel), a direct inhibitor of thrombin, has been approved by the FDA for use as an anticoagulant in patients with heparin-induced thrombocytopenia and thromboembolic complications....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Lepirudin for Heparin-Induced Thrombocytopenia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1036
Article Code: 1036b
Date: September 25, 1998
Volume: 40
Pages: 94-95
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1036
Article Code: 1036b
Date: September 25, 1998
Volume: 40
Pages: 94-95
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)